Tubular biomarkers to assess progression of diabetic nephropathy
- PMID: 21527942
- DOI: 10.1038/ki.2011.9
Tubular biomarkers to assess progression of diabetic nephropathy
Abstract
Despite aggressive management, many patients with diabetic nephropathy still develop end-stage renal disease. Accompanying tubulointerstitial damage is important in the progression of diabetic nephropathy. Markers of tubular damage, such as NGAL, KIM-1, and LFABP, have been proposed for monitoring the effectiveness of therapy. However, Nielsen et al. report a lack of an independent correlation between these biomarkers and glomerular filtration rate. Therefore, these markers seem to offer no improvement in the management of diabetic nephropathy.
Comment on
-
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26. Kidney Int. 2011. PMID: 21270761
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
